Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
Phase IIa study of marrow infiltrating lymphocytes (MILs), an adoptive T cell therapy, alone or in combination with nivolumab in non-small cell lung cancer (NSCLC)
Edelman, Martin, Lisberg, Aaron Elliott, Koczywas, Marianna, Creelan, Ben C., Seiz, Amanda, Lutz, Eric, Rudraraju, Lakshmi, DeOliveria, Elizabeth, Shah, Monil, Noonan, Kim, Johnson, Melissa Lynne
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Abstract 2745: The PLANET manufacturing process reproducibly generates high-quality neoantigen-targeted peripheral T cells (NPTs) for adoptive T cell therapy in the TiTAN clinical trial
Zope, Harshal, Nande, Rounak, Jain, Manish, Hubbard, Charley, Dowal, Louisa, Foti, James, Loizeaux, James, Cabral, Crystal, DeOliveira, Daniel B., Yang, Guohan, Reuter, Mercay, Flechtner, Jessica Baker, Stapleton, Raymond
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article
Abstract LB-335: Autologous whole-tumor antigen vaccination in combination with adoptive T cell therapy for patients with recurrent ovarian cancer
Kandalaft, Lana E., Tanyi, Janos, Chiang, Cheryl, Powell, Daniel, coukos, George
Published in Cancer research (Chicago, Ill.) (15.04.2013)
Published in Cancer research (Chicago, Ill.) (15.04.2013)
Get full text
Journal Article
Abstract LB-137: A new clinical-grade MEMS-based cell sorter for adoptive T-cell therapy
Yee, Cassian, Farrar, Erik, Grummitt, Daryl, Harley, John, Linton, Jim, Foster, John
Published in Cancer research (Chicago, Ill.) (15.04.2012)
Published in Cancer research (Chicago, Ill.) (15.04.2012)
Get full text
Journal Article
Gemcitabine, carboplatin, and Epstein–Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trial
Toh, H.C., Yang, M.-H., Wang, H.-M., Hsieh, C.Y., Chitapanarux, I., Ho, K.F., Hong, R.-L., Ang, M.K., Colevas, A.D., Sirachainan, E., Lertbutsayanukul, C., Ho, G.F., Nadler, E., Algazi, A., Lulla, P., Wirth, L.J., Wirasorn, K., Liu, Y.C., Ang, S.F., Low, S.H.J., Tho, L.M., Hasbullah, H.H., Brenner, M.K., Wang, W.-W., Ong, W.S., Tan, S.H., Horak, I., Ding, C., Myo, A., Samol, J.
Published in Annals of oncology (01.12.2024)
Published in Annals of oncology (01.12.2024)
Get full text
Journal Article
Cytotoxic T Lymphocytes Regenerated from iPS Cells Have Therapeutic Efficacy in a Patient-Derived Xenograft Solid Tumor Model
Kashima, Soki, Maeda, Takuya, Masuda, Kyoko, Nagano, Seiji, Inoue, Takamitsu, Takeda, Masashi, Kono, Yuka, Kobayashi, Takashi, Saito, Shigeyoshi, Higuchi, Takahiro, Ichise, Hiroshi, Kobayashi, Yuka, Iwaisako, Keiko, Terada, Koji, Agata, Yasutoshi, Numakura, Kazuyuki, Saito, Mitsuru, Narita, Shintaro, Yasukawa, Masaki, Ogawa, Osamu, Habuchi, Tomonori, Kawamoto, Hiroshi
Published in iScience (24.04.2020)
Published in iScience (24.04.2020)
Get full text
Journal Article
How do CARs work?: Early insights from recent clinical studies targeting CD19
Davila, Marco L., Brentjens, Renier, Wang, Xiuyan, Rivière, Isabelle, Sadelain, Michel
Published in Oncoimmunology (01.12.2012)
Published in Oncoimmunology (01.12.2012)
Get full text
Journal Article
Consumption of β-glucans to spice up T cell treatment of tumors: a review
de Graaff, Priscilla, Govers, Coen, Wichers, Harry J., Debets, Reno
Published in Expert opinion on biological therapy (03.10.2018)
Published in Expert opinion on biological therapy (03.10.2018)
Get full text
Journal Article
Autologous whole-tumor antigen vaccination in combination with adoptive T cell therapy for patients with recurrent ovarian cancer
Kandalaft, Lana E, Chiang, Cheryl, Zsiros, Emese, Tanyi, Janos, Powell, Daniel, Mick, Rosemarie, Coukos, George
Published in Journal for immunotherapy of cancer (07.11.2013)
Published in Journal for immunotherapy of cancer (07.11.2013)
Get full text
Journal Article
A phase 1, first-in-human (FIH) study of adenovirally transduced autologous macrophages engineered to contain an anti-HER2 chimeric antigen receptor (CAR) in subjects with HER2 overexpressing solid tumors
Reiss, Kim Anna, Yuan, Yuan, Barton, Debora, Cushing, Daniel, Ronczka, Amy, Klichinsky, Michael, Dees, Elizabeth Claire
Published in Journal of clinical oncology (01.02.2022)
Published in Journal of clinical oncology (01.02.2022)
Get full text
Journal Article
A phase 1, first in human study of adenovirally transduced autologous macrophages engineered to contain an anti-HER2 chimeric antigen receptor (CAR) in subjects with HER2 overexpressing solid tumors
Bauml, Joshua, Grover, Natalie Sophia, Ronczka, Amy, Cushing, Daniel, Klichinsky, Michael, Barton, Debora, Dees, Elizabeth Claire
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article